Skip to content

Effective Care Management of Depressed Diabetes Patients (The Positive Steps Study)

Effective Care Management of Depressed Diabetes Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01106885
Enrollment
339
Registered
2010-04-20
Start date
2005-05-31
Completion date
2011-04-30
Last updated
2015-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Depression

Keywords

Diabetes, Depression, Telephone Care Management, Medication Care Management (MCM), Cognitive Behavioral Therapy (CBT)

Brief summary

Evaluation of telephone care management intervention designed to improve outcomes among depressed diabetes patients.

Detailed description

Research Plan: 382 patients ages 21-80, including 177 women, and 123 Blacks from the Ann Arbor VA HCS, UM, and the Genesys Health Care System in Flint. Patients will be randomized to: (1) brief education about depression, diabetes self-care, and physical activity; or (2) telephone care management including antidepressant medication care management (MCM) and/or cognitive behavioral therapy (CBT). The MCM module uses a standard algorithm to identify efficacious antidepressants and promote adherence. The CBT module addresses symptoms, exercise, and communication skills. Methods: Surveys: Patients will complete clinic-based surveys at baseline and 12-months to measure their health status, self-care, provider-patient communication, and resource use. At 4 months, they will complete a mailed questionnaire to capture short-term changes in depressive symptoms, walking, patient-provider communication, medication adherence, and quality-of-life. Physiologic Measures: At baseline and 12-months, patients' A1c and cholesterol will be measured via a fingerstick blood test. We also will measure blood pressure, height, and weight. With patients' 4-month mailed surveys, they will complete fingerstick A1c tests and return the results via mail. The blood tests are identical to those diabetes patients use to self-monitor their blood glucose. Pedometers: We will measure distance walked at baseline, 4 months, and 12 months using a pedometer. Patients will record their walk distances for one week and return the results via mail. Electronic data: Utilization and billing databases will be used to identify health service utilization (ER visits, outpatient care, hospitalizations) occurring during patients' participation and the prior 12 months. Physician feedback. At patients' 12-month assessment, the physician will complete a brief survey about the patient's communication style. All patients will provide written consent administered prior to their face-to-face screening and baseline interviews. Physician 12-month surveys about patients' communication style will be anonymous.

Interventions

BEHAVIORALMedication Care Management (MCM)

* Basic physical activity counseling * Notify PCP and facilitate initiation of antidepressants * Medication monitoring calls at 1, 2, 4, 6, 8, 10, and 12 weeks\* * 1/mo monitoring in continuation phase (mos. 4-12)\* * Report & recommendations to PCP after each patient call * Note: \*average of 10 minutes of telephone time each (series is repeated if second antidepressant trial is needed)

* Notify PCP * CBT Manual * Weekly CBT focused counseling for 12 weeks\*\* * Monthly CBT in months 4-12\*\* * Behavioral physical activity counseling * Report & recommendations to PCP after each patient call * Note: \*\*average of 50 minutes of telephone time each

Sponsors

US Department of Veterans Affairs
CollaboratorFED
Genesys Health System
CollaboratorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

. Patients must meet all of the following criteria: * Active Diabetes (Type 1 & 2) * Diagnosis of depression * Using hypoglycemic medications * At least 1 outpatient visit in last 12 months * At least 21 years old

Exclusion criteria

. Patients who have any of the following will be excluded: * Limited life expectancy (heart failure/ on oxygen/ advanced stage cancer/ dialysis) * End stage renal disease * Lung cancer * Dementia * Bipolar * Schizophrenia * Can't speak English * Memory problems * Alcohol problems * Illegal drug use * Minimal depressive symptoms * Blood pressure 180/110 or higher * Problems with loss of consciousness * Can't walk 10 minutes on level surface * Not planning to get their care at study site * PCP not affiliated with study site * Are not on a stable regimen (change in depression Rx in last 28-30 days) * Type 1 diabetic if diagnosed before age 15

Design outcomes

Primary

MeasureTime frame
Participant HbA1c levelsone year
Participant cardiovascular risk indexone year

Secondary

MeasureTime frameDescription
Health-related quality of lifeone year
Proximal intervention targetsone year(e.g., depressive symptoms, physical activity levels, and provider-patient communication)
Resource useone year
Treatment satisfactionone year
Other self-care behaviorsone year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026